State Street SPDR S&P Biotech ETF (XBI) is upgraded to buy as bullish momentum and reasonable valuation converge amid ...

When scientists at Bac 3 Gel hear from potential customers, they typically express a mixture of frustration, curiosity, and skepticism, Sebastião van Uden, PhD, the company’s CEO, tells GEN. Usually, ...

K-Beauty is reshaping luxury skincare through regenerative science, advanced ingredients and innovation, redefining what premium beauty means.

Cambridge, U.K.-based Broken String Biosciences launched BaseMap™ ABE, built on the company’s INDUCE-seq ® technology, to support adenine base editing (ABE) applications. Base editing is gaining ...

Capital continues to flow toward clinical-stage and platform biotech companies, with a wave of new deals, partnerships, and ...

A new generation of female entrepreneurs are leading a monumental shift in the beauty industry, replacing fossil fuel-derived ingredients with bio-based alternatives.

Workforce cuts this year at seven companies involved in recent mergers and acquisitions will cost over 1,300 employees their ...

Biotechnology investors remain confident in the sector's outlook even after a major comeback this year — and they're picking their positions. The healthcare subsector has quietly become one of the ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

Kerry Latin America CEO Marcio Luz discusses GLP-1-driven food innovation, rising protein demand, M&A ambitions, biotechnology investment and the consumer trends reshaping one of the world's ...

The diagnostics and life sciences tools sector is attracting continued investor interest across both private equity and large ...

PDS0301 Phase 2 clinical data in mCRC and a comprehensive review of capital allocation priorities drive strategic refocus designed to maximize long-term shareholder value ...